Abstract:Alternative splicing is crucial for increasing eukaryotic cell transcriptome and proteome diversity Changes in alternative splicing play a key role in cell differentiation and tissue development, and aberrations in this process have been associated with diseases Despite its importance, the exact mechanisms for regulating alternative splicing are poorly understood Several epigenetic marks, such as histone modification H3K36me3, have previously been associated with changes in alternative splicing Here, we leverage the EpiATLAS data set to systematically re-evaluate evidence for epigenetic control of alternative splicing. We used SUPPA2 to calculate percentage spliced-in (PSI) values for skipped exons and retained introns and integrated this information with histone ChIP-seq and DNA methylation data In addition to genome-wide association analysis with partial correlation and machine learning, we perform locus-specific PSI modeling on individual alternative splicing events The latter represents a new contribution enabled by the unprecedented number of uniformly processed datasets in EpiATLAS. Our results confirm previously reported global associations of DNAm and H3K36me3 for exon inclusion and emphasize the importance of intrinsic features for genome-wide associations. On an event-specific level, trying to identify co-transcriptionally spliced events with epigenetic influence, we show that overall gene expression biases locus-specific analyses Further, we show that epigenetic signal can predict PSI value in cis and trans, indicating sample-specific epigenetic fingerprints that distort across-sample analyses Specifically, generalized linear models select epigenetic features predictive for PSI values not only in their genomic vicinity but also on different chromosomes. Our study demonstrates that epigenetic marks are associated with the alternative inclusion of exons and introns Without a mechanistic explanation for these associations, our work emphasizes the need for more detailed research into the relationship between epigenetic changes and transcriptome diversity.

Bioinformatics challenges and perspectives when studying the effect of epigenetic modifications on alternative splicing

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Genomics of alternative splicing: evolution, development and pathophysiology

A systematic analysis of the effects of splicing on the diversity of post-translational modifications in protein isoforms

Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects

The Application of Bioinformatics in the Research of Alternative Splicing

RNA Structures in Alternative Splicing and Back‐splicing

Prospects of Identifying Alternative Splicing Events from Single-Cell RNA Sequencing Data

Epigenetic Regulation of Alternative Splicing.

Revisiting Evidence for Epigenetic Control of Alternative Splicing

The function of alternative splicing in the proteome: rewiring protein interactomes to put old functions into new contexts

From computational models of the splicing code to regulatory mechanisms and therapeutic implications

Alternative splicing: Human disease and quantitative analysis from high-throughput sequencing

Computational approaches for detecting disease-associated alternative splicing events

Mechanisms of Neuronal Alternative Splicing and Strategies for Therapeutic Interventions

Chromatin and Genomic determinants of alternative splicing.

A–Z of Epigenetic Readers: Targeting Alternative Splicing and Histone Modification Variants in Cancer

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

Epigenetics and alternative splicing in cancer: old enemies, new perspectives

Prioritizing Single-Nucleotide Variations That Potentially Regulate Alternative Splicing.

In silico and in cellulo approaches for functional annotation of human protein splice variants